MIELE, GIUSEPPINA
 Distribuzione geografica
Continente #
NA - Nord America 181
EU - Europa 171
AS - Asia 50
AF - Africa 3
Totale 405
Nazione #
US - Stati Uniti d'America 181
IE - Irlanda 100
IT - Italia 29
SG - Singapore 23
DE - Germania 18
CN - Cina 16
FI - Finlandia 6
CZ - Repubblica Ceca 5
GB - Regno Unito 5
IN - India 5
KR - Corea 5
BE - Belgio 4
MA - Marocco 3
SE - Svezia 2
FR - Francia 1
JP - Giappone 1
LU - Lussemburgo 1
Totale 405
Città #
Dublin 100
Chandler 33
New York 22
Singapore 17
Cambridge 13
Boardman 10
Munich 10
Naples 10
Roxbury 8
Princeton 7
Pasadena 6
Beijing 5
Brno 5
Milan 5
Seoul 5
Bremen 4
Brussels 4
Helsinki 4
Meknes 3
Norwich 3
Pune 3
Rockville 3
Ann Arbor 2
Ashburn 2
Hyderabad 2
Lappeenranta 2
Atlanta 1
Battipaglia 1
Grafing 1
Luxembourg 1
L’Aquila 1
Napoli 1
New Haven 1
Norwalk 1
Pognano 1
Putignano 1
Sala Consilina 1
Sulmona 1
Tokyo 1
Woodbridge 1
Totale 302
Nome #
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic 51
Telemedicine application to headache: a critical review 49
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells 36
Source of medical information and behavioral seeking patterns in patients affected with Friedreich’s ataxia and their caregivers: a survey study 30
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study 29
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study 28
Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic 26
Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series 22
Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis 21
Expectations for the high-energy neutrino detection from starburst galaxies with KM3NeT/ARCA 20
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic review 20
MRI and steroid-responsive encephalopathy associated with autoimmune thyroiditis: first report of conus medullaris involvement and literature review of the known neuroimaging profiles 14
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 13
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study 13
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis 11
Viral pericarditis following ocrelizumab in a multiple sclerosis patient 10
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study 10
Pain, quality of life, and religiosity in people with multiple sclerosis 9
Validation of the swallowing disturbance questionnaire in people with multiple sclerosis 6
Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learning 5
Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab 2
Totale 425
Categoria #
all - tutte 3.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.470


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202253 0 0 3 1 4 4 0 1 1 0 13 26
2022/2023174 27 7 2 3 9 9 1 7 89 4 7 9
2023/2024187 10 12 13 14 34 32 11 1 5 1 7 47
2024/202511 2 9 0 0 0 0 0 0 0 0 0 0
Totale 425